TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 63 filers reported holding TREACE MED CONCEPTS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,480,330 | -80.2% | 570,582 | -61.4% | 0.10% | -79.7% |
| Q2 2023 | $37,784,627 | +99.4% | 1,477,116 | +96.4% | 0.48% | +79.3% |
| Q1 2023 | $18,947,666 | +6.9% | 752,190 | -2.4% | 0.27% | +0.8% |
| Q4 2022 | $17,721,083 | +13.3% | 770,817 | +8.8% | 0.26% | +11.4% |
| Q3 2022 | $15,640,000 | +142.9% | 708,676 | +57.9% | 0.24% | +127.9% |
| Q2 2022 | $6,438,000 | -24.6% | 448,941 | -0.6% | 0.10% | -1.0% |
| Q1 2022 | $8,544,000 | +54.1% | 451,835 | +51.9% | 0.10% | +84.2% |
| Q4 2021 | $5,546,000 | -34.0% | 297,514 | -4.7% | 0.06% | -43.0% |
| Q3 2021 | $8,398,000 | -14.6% | 312,204 | -0.8% | 0.10% | -23.1% |
| Q2 2021 | $9,834,000 | – | 314,573 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,907,823 | $25,011,560 | 2.31% |
| FORMULA GROWTH LTD | 222,269 | $2,913,947 | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,193,939 | $15,652,540 | 0.94% |
| EMERALD ADVISERS, LLC | 1,473,281 | $19,314,713 | 0.94% |
| Perceptive Advisors | 1,834,060 | $24,044,527 | 0.80% |
| NEXT CENTURY GROWTH INVESTORS LLC | 512,738 | $6,721,995 | 0.73% |
| OBERWEIS ASSET MANAGEMENT INC/ | 355,600 | $4,661,916 | 0.50% |
| Novo Holdings A/S | 360,000 | $4,719,600 | 0.35% |
| TimesSquare Capital Management, LLC | 1,433,429 | $18,792 | 0.29% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 677,733 | $8,885,080 | 0.18% |